Intratumoral T‐cell receptor repertoire is predictive of interim PET scan results in patients with diffuse large B‐cell lymphoma treated with rituximab/cyclophosphamide/doxorubicin/prednisolone/vincristine (R‐CHOP) chemoimmunotherapy

Intratumoral T‐cell receptor repertoire is predictive of interim PET scan results in patients with diffuse large B‐cell lymphoma treated with rituximab/cyclophosphamide/doxorubicin/prednisolone/vincristine (R‐CHOP) chemoimmunotherapy

Abstract Objectives A diverse intratumoral T‐cell receptor (TCR) repertoire is associated with improved survival in diffuse large B‐cell lymphoma (DLBCL) treated with rituximab/cyclophosphamide/doxorubicin/prednisolone/vincristine (R‐CHOP) chemoimmunotherapy. We explored the impact of intratumoral T...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Mohamed Shanavas, Soi‐Cheng Law, Mark Hertzberg, Rodney J Hicks, John F Seymour, Zhixiu Li, Lilia Merida de Long, Karthik Nath, Muhammed B Sabdia, Jay Gunawardana, Maher K Gandhi, Colm Keane
Formato: article
Lenguaje:EN
Publicado: Wiley 2021
Materias:
immunotherapy
interim PET
lymphoma
TCR repertoire
Immunologic diseases. Allergy
RC581-607
Acceso en línea:https://doaj.org/article/50bba13efe444391a61f0d8ffaa50fb2
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

https://doaj.org/article/50bba13efe444391a61f0d8ffaa50fb2

Ejemplares similares